OXIDATIVE STRESS AS A CAUSE OF NIGRAL CELL-DEATH IN PARKINSONS-DISEASE AND INCIDENTAL LEWY BODY DISEASE

被引:406
作者
JENNER, P
DEXTER, DT
SIAN, J
SCHAPIRA, AHV
MARSDEN, CD
机构
[1] ROYAL FREE HOSP,SCH MED,DEPT NEUROL SCI,LONDON,ENGLAND
[2] UNIV LONDON,NATL HOSP,INST NEUROL,DEPT CLIN NEUROL,PARKINSONS DIS SOC,LONDON,ENGLAND
关键词
D O I
10.1002/ana.410320714
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We examine the evidence for free radical involvement and oxidative stress in the pathological process underlying Parkinson's disease, from postmortem brain tissue. The concept of free radical involvement is supported by enhanced basal lipid peroxidation in substantia nigra in patients with Parkinson's disease, demonstrated by increased levels of malondialdehyde and lipid hydroperoxides. The activity of many of the protective mechanisms against oxidative stress does not seem to be significantly altered in the nigra in Parkinson's disease. Thus, activities of catalase and glutathione peroxidase are more or less unchanged, as are concentrations of vitamin C and vitamin E. The activity of mitochondrial superoxide dismutase and the levels of the antioxidant ion zinc are, however, increased, which may reflect oxidative stress in substantia nigra. Levels of reduced glutathione are decreased in nigra in Parkinson's disease; this decrease does not occur in other brain areas or in other neurodegenerative illnesses affecting this brain region (i.e., multiple system atrophy, progressive supranuclear palsy). Altered glutathione metabolism may prevent inactivation of hydrogen peroxide and enhance formation of toxic hydroxyl radicals. In brain material from patients with incidental Lewy body disease (presymptomatic Parkinson's disease), there is no evidence for alterations in iron metabolism and no significant change in mitochondrial complex I function. The levels of reduced glutathione in substantia nigra, however, are reduced to the same extent as in advanced Parkinson's disease. These data suggest that changes in glutathione function are an early component of the pathological process of Parkinson's disease. The data presented suggest (1) there is oxidative stress in the substantia nigra at the time of death in advanced Parkinson's disease that manifests in terms of increased lipid peroxidation, superoxide dismutase activity, and zinc levels; (2) there is a major impairment of the glutathione pathway in Parkinson's disease; and (3) alterations in reduced glutathione levels may occur very early in the illness.
引用
收藏
页码:S82 / S87
页数:6
相关论文
共 38 条
[21]  
MCGEER PL, 1989, PARKINSONISM AGING, P25
[22]   GLUTATHIONE DEFICIENCY PRODUCED BY INHIBITION OF ITS SYNTHESIS, AND ITS REVERSAL - APPLICATIONS IN RESEARCH AND THERAPY [J].
MEISTER, A .
PHARMACOLOGY & THERAPEUTICS, 1991, 51 (02) :155-194
[23]   BRAIN AMINO-ACIDS AND GLUTATHIONE IN PROGRESSIVE SUPRANUCLEAR PALSY [J].
PERRY, TL ;
HANSEN, S ;
JONES, K .
NEUROLOGY, 1988, 38 (06) :943-946
[24]   IDIOPATHIC PARKINSONS-DISEASE, PROGRESSIVE SUPRANUCLEAR PALSY AND GLUTATHIONE METABOLISM IN THE SUBSTANTIA-NIGRA OF PATIENTS [J].
PERRY, TL ;
YONG, VW .
NEUROSCIENCE LETTERS, 1986, 67 (03) :269-274
[25]   PARKINSONS-DISEASE - A DISORDER DUE TO NIGRAL GLUTATHIONE DEFICIENCY [J].
PERRY, TL ;
GODIN, DV ;
HANSEN, S .
NEUROSCIENCE LETTERS, 1982, 33 (03) :305-310
[26]   CELLULAR AND REGIONAL DISTRIBUTION OF REDUCED GLUTATHIONE IN THE NERVOUS-SYSTEM OF THE RAT - HISTOCHEMICAL-LOCALIZATION BY MERCURY ORANGE AND ORTHO-PHTHALDIALDEHYDE-INDUCED HISTOFLUORESCENCE [J].
PHILBERT, MA ;
BEISWANGER, CM ;
WATERS, DK ;
REUHL, KR ;
LOWNDES, HE .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1991, 107 (02) :215-227
[27]   TRANSITION-METALS, FERRITIN, GLUTATHIONE, AND ASCORBIC-ACID IN PARKINSONIAN BRAINS [J].
RIEDERER, P ;
SOFIC, E ;
RAUSCH, WD ;
SCHMIDT, B ;
REYNOLDS, GP ;
JELLINGER, K ;
YOUDIM, MBH .
JOURNAL OF NEUROCHEMISTRY, 1989, 52 (02) :515-520
[28]   1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) AND FREE-RADICALS INVITRO [J].
ROSSETTI, ZL ;
SOTGIU, A ;
SHARP, DE ;
HADJICONSTANTINOU, M ;
NEFF, NH .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (23) :4573-4574
[29]   A SELECTIVE INCREASE IN PARTICULATE SUPEROXIDE-DISMUTASE ACTIVITY IN PARKINSONIAN SUBSTANTIA NIGRA [J].
SAGGU, H ;
COOKSEY, J ;
DEXTER, D ;
WELLS, FR ;
LEES, A ;
JENNER, P ;
MARSDEN, CD .
JOURNAL OF NEUROCHEMISTRY, 1989, 53 (03) :692-697
[30]   STRIATAL FUNCTION IN NORMAL AGING - IMPLICATIONS FOR PARKINSONS-DISEASE [J].
SAWLE, GV ;
COLEBATCH, JG ;
SHAH, A ;
BROOKS, DJ ;
MARSDEN, CD ;
FRACKOWIAK, RSJ .
ANNALS OF NEUROLOGY, 1990, 28 (06) :799-804